Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid cell–synthesized coagulation factor X dampens antitumor immunity
Claudine Graf, Petra Wilgenbus, Sven Pagel, et al.
Science Immunology (2019) Vol. 4, Iss. 39
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Coagulome and the tumor microenvironment: an actionable interplay
Antoine Galmiche, Janusz Rak, Lubka T. Roumenina, et al.
Trends in cancer (2022) Vol. 8, Iss. 5, pp. 369-383
Open Access | Times Cited: 74
HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription
Ziping Niu, Chen Chen, Siyu Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 39
Lipid presentation by the protein C receptor links coagulation with autoimmunity
Nadine Müller‐Calleja, Anne Hollerbach, Jennifer Royce, et al.
Science (2021) Vol. 371, Iss. 6534
Open Access | Times Cited: 100
Increased incidence of venous thromboembolism with cancer immunotherapy
Joanna Roopkumar, Shadi Swaidani, Ann S. Kim, et al.
Med (2021) Vol. 2, Iss. 4, pp. 423-434.e3
Open Access | Times Cited: 96
Beyond thrombosis: the impact of tissue factor signaling in cancer
Dusten Unruh, Craig Horbinski
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 80
Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities
Alexander T. Bauer, Christian Gorzelanny, Christoffer Gebhardt, et al.
Cancer Treatment Reviews (2021) Vol. 102, pp. 102322-102322
Open Access | Times Cited: 59
Leveraging big data of immune checkpoint blockade response identifies novel potential targets
Yacine Barèche, Deirdre Kelly, Farnoosh Abbas‐Aghababazadeh, et al.
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1304-1317
Closed Access | Times Cited: 47
Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy
Alan E. Mast, Wolfram Ruf
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 6, pp. 1290-1300
Open Access | Times Cited: 44
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
Seyed Esmaeil Ahmadi, Ashkan Shabannezhad, Amir Kahrizi, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 22
A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes
Zhuoqi Li, Ling Chen, Zhigang Wei, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors—A Retrospective, Real-World Cohort Study
Maximilian Haist, Henner Stege, Saskia Pemler, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5103-5103
Open Access | Times Cited: 41
Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management
Tzu‐Fei Wang, Marc Carrier
Current Oncology (2023) Vol. 30, Iss. 3, pp. 3032-3046
Open Access | Times Cited: 20
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy
Vincenzo Russo, Luigi Falco, Viviana Tessitore, et al.
Life (2023) Vol. 13, Iss. 9, pp. 1888-1888
Open Access | Times Cited: 17
Coagulation Protease-Driven Cancer Immune Evasion: Potential Targets for Cancer Immunotherapy
Subhojit Paul, Tanmoy Mukherjee, Kaushik Das
Cancers (2024) Vol. 16, Iss. 8, pp. 1568-1568
Open Access | Times Cited: 6
Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment
Hugo Ten Cate, Tomasz J. Guzik, John W. Eikelboom, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 9, pp. 2030-2044
Open Access | Times Cited: 45
Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19
Anne Hollerbach, Nadine Müller‐Calleja, Denise Pedrosa, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 9, pp. 2335-2347
Open Access | Times Cited: 35
Thrombotic Complications Associated with Immune Checkpoint Inhibitors
Tzu‐Fei Wang, Alok A. Khorana, Marc Carrier
Cancers (2021) Vol. 13, Iss. 18, pp. 4606-4606
Open Access | Times Cited: 34
VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance
Evelien Schaafsma, Walburga Croteau, Mohamed ElTanbouly, et al.
Cancer Immunology Research (2022) Vol. 11, Iss. 1, pp. 38-55
Open Access | Times Cited: 26
Targeting myeloid cell coagulation signaling blocks MAP kinase/TGF-β1–driven fibrotic remodeling in ischemic heart failure
Venkata Garlapati, Michael Molitor, Thomas Michna, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 4
Open Access | Times Cited: 25
Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
Zhiqiang Ren, Yinyin Xue, Liang Liu, et al.
Cancer Letters (2023) Vol. 565, pp. 216221-216221
Closed Access | Times Cited: 14
The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy
Mari Tinholt, Xavier Tekpli, Lilly Anne Torland, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 5, pp. 1319-1335
Open Access | Times Cited: 5
Fitusiran reduces bleeding in Factor X-deficient mice
Sebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, et al.
Blood (2024) Vol. 144, Iss. 2, pp. 227-236
Closed Access | Times Cited: 5
A systematic overview of single-cell transcriptomics databases, their use cases, and limitations
Mahnoor N. Gondal -, Syed Hamad Hassan Shah, Arul M. Chinnaiyan, et al.
Frontiers in Bioinformatics (2024) Vol. 4
Open Access | Times Cited: 5
Coagulation and inflammation in cancer: Limitations and prospects for treatment
Arun Kumar Singh, Rishabha Malviya
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188727-188727
Closed Access | Times Cited: 22
Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
Areez Shafqat, Mohamed H. Omer, Eman Nayaz Ahmed, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top